Darunavir/ritonavir − a POWERful option for HIV

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.622, 2011-01, pp. : 3-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ritonavir-boosted darunavir: a powerful option for treatment-experienced HIV-1-infected patients

By Menééndez-Arias Luis Matamoros Tania ÁÁlvarez Mar

Future Virology, Vol. 3, Iss. 5, 2008-09 ,pp. : 423-434

Future Medicine

Access to resources Recommend Favorite

Darunavir + ritonavir superior to lopinavir/ritonavir for HIV infection

Inpharma, Vol. 1, Iss. 1596, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Darunavir a powerful contender in HIV infections

Inpharma, Vol. 1, Iss. 1504, 2005-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Model‐Based Once‐Daily Darunavir/Ritonavir Dosing Recommendations in Pediatric HIV‐1‐Infected Patients Aged ≥3 to

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 4, Iss. 7, 2015-08 ,pp. : 406-414

John Wiley & Sons Inc

Access to resources Recommend Favorite

The combination of darunavir and ritonavir appears to be effective for treatment-experienced children and adolescents with HIV-1 infections

Inpharma, Vol. 1, Iss. 1625, 2008-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite